Researchers in Europe are holding their collective breath as a European court tries to decide whether to ban patents on technologies that use human embryonic stem cells, says Veronique Greenwood at the 80beats blog. Scientists warn that if this ban is imposed and labs can no longer make money from their discoveries, regenerative medicine will not go further than the bench, she adds.